Dallas, TX, United States of America

Vishal D Patel

This inventor holds 2 USPTO granted patents and 11 published patent applications and 1 EPO patent. Top assignees: Regulus Therapeutics Inc., The University of Texas System. Active years: 2020-2021.

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 3.0

ph-index = 1


Location History:

  • Austin, TX (US) (2020)
  • Dallas, TX (US) (2021)

Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Vishal D Patel: Innovator in Kidney Disease Treatment

Introduction

Vishal D Patel is a notable inventor based in Dallas, TX (US). He has made significant contributions to the field of medical research, particularly in the treatment of polycystic kidney disease. With a total of 2 patents, his work has the potential to impact many lives.

Latest Patents

Patel's latest patents focus on innovative methods for treating polycystic kidney disease. These methods involve the use of modified oligonucleotides targeted to miR-17, which aim to provide effective treatment options for individuals suffering from autosomal dominant polycystic kidney disease.

Career Highlights

Throughout his career, Vishal D Patel has worked with prominent organizations such as Regulus Therapeutics Inc. and the University of Texas System. His experience in these institutions has allowed him to develop and refine his research in the medical field.

Collaborations

Some of his notable coworkers include John R Androsavich and B Nelson Chau. Their collaboration has contributed to the advancement of research in kidney disease treatment.

Conclusion

Vishal D Patel's innovative work in the treatment of polycystic kidney disease showcases his dedication to improving healthcare solutions. His patents and collaborations reflect a commitment to advancing medical research and providing hope for patients.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…